River Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Sell
93,102
-737
-0.8% -$85.1K 1.29% 23
2025
Q4
$9.88M Buy
93,839
+11,915
+15% +$1.12M 1.11% 24
2025
Q3
$6.88M Buy
81,924
+15,906
+24% +$1.31M 0.8% 32
2025
Q2
$5.23M Buy
66,018
+11,853
+22% +$942K 0.65% 41
2025
Q1
$4.86M Buy
54,165
+7,648
+16% +$714K 0.68% 41
2024
Q4
$4.63M Buy
46,517
+2,199
+5% +$227K 0.61% 43
2024
Q3
$5.03M Buy
44,318
+3,665
+9% +$435K 0.67% 41
2024
Q2
$5.03M Buy
40,653
+3,205
+9% +$413K 0.72% 39
2024
Q1
$4.94M Buy
37,448
+3,026
+9% +$373K 0.72% 37
2023
Q4
$3.75M Buy
34,422
+1,051
+3% +$109K 0.6% 47
2023
Q3
$3.44M Buy
33,371
+3,704
+12% +$399K 0.61% 45
2023
Q2
$3.42M Buy
29,667
+3,219
+12% +$365K 0.58% 50
2023
Q1
$2.81M Buy
26,448
+3,701
+16% +$400K 0.51% 60
2022
Q4
$2.52M Buy
22,747
+3,892
+21% +$398K 0.49% 62
2022
Q3
$1.62M Buy
18,855
+3,780
+25% +$337K 0.35% 78
2022
Q2
$1.37M Buy
15,075
+3,028
+25% +$268K 0.25% 90
2022
Q1
$989K Buy
12,047
+1,557
+15% +$123K 0.16% 120
2021
Q4
$804K Buy
10,490
+1,467
+16% +$117K 0.12% 128
2021
Q3
$678K Buy
9,023
+627
+7% +$47.7K 0.12% 128
2021
Q2
$653K Sell
8,396
-655
-7% -$48.7K 0.11% 132
2021
Q1
$666K Buy
9,051
+740
+9% +$54.6K 0.13% 129
2020
Q4
$649K Buy
8,311
+1,084
+15% +$82.9K 0.14% 123
2020
Q3
$572K Buy
7,227
+1,626
+29% +$127K 0.15% 125
2020
Q2
$413K Buy
5,601
+126
+2% +$9.48K 0.13% 130
2020
Q1
$402K Buy
5,475
+163
+3% +$12.8K 0.16% 116
2019
Q4
$461K Sell
5,312
-779
-13% -$64K 0.16% 118
2019
Q3
$489K Sell
6,091
-571
-9% -$45.8K 0.18% 109
2019
Q2
$533K Buy
6,662
+4
+0.1% +$306 0.21% 103
2019
Q1
$528K Sell
6,658
-144
-2% -$10.8K 0.22% 106
2018
Q4
$496K Buy
6,802
+5
+0.1% +$353 0.22% 100
2018
Q3
$460K Sell
6,797
-359
-5% -$22.9K 0.17% 124
2018
Q2
$414K Sell
7,156
-989
-12% -$55.8K 0.16% 122
2018
Q1
$423K Sell
8,145
-3,076
-27% -$166K 0.18% 122
2017
Q4
$602K Buy
11,221
+2,693
+32% +$149K 0.25% 106
2017
Q3
$521K Sell
8,528
-780
-8% -$47.3K 0.24% 109
2017
Q2
$569K Sell
9,308
-122
-1% -$7.43K 0.26% 106
2017
Q1
$572K Sell
9,430
-1,308
-12% -$79.4K 0.28% 103
2016
Q4
$603K Sell
10,738
-1,823
-15% -$107K 0.31% 100
2016
Q3
$748K Sell
12,561
-4,572
-27% -$267K 0.41% 86
2016
Q2
$942K Sell
17,133
-1,252
-7% -$66.6K 0.54% 70
2016
Q1
$928K Buy
18,385
+409
+2% +$20K 0.55% 65
2015
Q4
$906K Buy
17,976
+9,696
+117% +$489K 0.57% 65
2015
Q3
$390K Buy
8,280
+113
+1% +$6K 0.27% 109
2015
Q2
$444K Sell
8,167
-589
-7% -$33K 0.28% 104
2015
Q1
$480K Buy
+8,756
New +$496K 0.3% 104

Other funds holding MRK

River Wealth Advisors's MRK Position: Q1 2026 in Review

River Wealth Advisors reduced its Merck (MRK) stake by 0.79% in Q1 2026, selling an estimated $85.1K and leaving 93,102 shares worth $11.2M. The position accounts for 1.29% of the portfolio, ranked #23.

River Wealth Advisors first reported a position in MRK in Q1 2015 and has held it in 45 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • River Wealth Advisors held 93,102 shares of Merck worth $11.2M as of Q1 2026.
  • River Wealth Advisors sold 737 Merck shares in Q1 2026, an estimated $85.1K.
  • Merck made up 1.29% of River Wealth Advisors's portfolio in Q1 2026, its #23 holding.
  • River Wealth Advisors first reported a position in Merck in Q1 2015 and has held it in 45 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on River Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.